Skip to main content
  • Careers
  • Contact
  • en   it

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

MolMed is now part of AGC Biologics

Learn more

AGC Biologics

Investors

Delisting
Delisting ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Final results
Final results ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Provisional results sell-out
Provisional results sell-out ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Half-year financial report - 30 06 2020
Half-year financial report - 30 06 2020 ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

PR_ integrating PR resignation directors
PR_ integrating PR resignation directors ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Resignation directors
Resignation directors ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

AGC half-year financial results
AGC half-year financial results ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Sell-out procedure
Sell-out procedure ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

Definitive results of the Offer
Definitive results of the Offer ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Investors

MolMed - First-half 2020 financial results
MolMed - First-half 2020 financial results ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe to press releases

By subscribing to this newsletter, you confirm that you have read the Privacy Policy and agree to receive MolMed's press releases

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations. 
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

Leading the way in Cell and Gene therapy

MolMed S.p.A.
Via Olgettina, 58
20132 Milano, Italy
+39 0221277.1
info@molmed.com
Privacy & Cookie Policy

About us

About us ▾

aboutus

  • Business model
  • Our Team
  • Scientific advisory board
  • Hystory
  • Careers

Pipeline

Pipeline ▾

pipeline

  • Our products
  • CAR-T platform
  • CAR-NK

GMP Solutions

GMP Solutions ▾

GMP Solutions footer ENG

  • Our services
  • Viral Vectors
  • Genetically Modified Cells
  • Facilities

Investors

Investors ▾

Investors

  • Stock informations
  • Presentations
  • Notices
  • Events
  • Financial Calendar

Governance

Governance ▾

Governance

  • Corporate governance model
  • Corporate governance rules
  • Business ethics
  • Corporate governance reports

News & Events

News ▾

News

  • News & Events
MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italia | Tel. +39 0221277.1 - Fax +39 02 21277.325 | info@molmed.com - www.molmed.com
Capitale Sociale € 21.819.020,83 i.v. - REA n.1506630 - N. iscrizione Reg. Imprese di Milano - C. F. e P. IVA 11887610159